跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOCLA TABLETS 625 mg - HSA Drug Approval Details
Approvals
/
HSA
/
AMOCLA TABLETS 625 mg
Approved
THERAPEUTIC
AMOCLA TABLETS 625 mg
Penmix Ltd
🇸🇬 Health Sciences Authority
Approval Date
Nov 9, 1999
Approval ID
385c832f9cdabff2
Company
Penmix Ltd
Type
Therapeutic
Approval Details
Approval Id
385c832f9cdabff2
Drug Name
AMOCLA TABLETS 625 mg
Product Name
AMOCLA TABLETS 625 mg
Approval Number
SIN11219P
Approval Date
1999-11-09
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01CR02
Atc Item Name
amoxicillin and beta-lactamase inhibitor
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
CLAVULANATE POTASSIUM EQV CLAVULANIC ACID
125 mg
AMOXICILLIN TRIHYDRATE EQV AMOXICILLIN
500 mg
AMOXICILLIN TRIHYDRATE EQV AMOXICILLIN
500 mg
CLAVULANATE POTASSIUM EQV CLAVULANIC ACID
125 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 9, 1999
Approval ID
385c832f9cdabff2
Type
Therapeutic
Back to HSA Approvals